NOVATED AND RESTATED TECHNOLOGY LICENSE AGREEMENT dated as of June 17, 2004 between GPI NIL HOLDINGS, INC., GUILFORD PHARMACEUTICALS INC., SYMPHONY NEURO DEVELOPMENT COMPANY and SNDC HOLDINGS LLCTechnology License Agreement • November 24th, 2004 • Guilford Pharmaceuticals Inc • Pharmaceutical preparations • New York
This NOVATED AND RESTATED TECHNOLOGY LICENSE AGREEMENT (this “Agreement”) is made and effective as of June 17, 2004 (the “Effective Date”) by and between GPI NIL Holdings, Inc., a Delaware corporation (“GPI”), Guilford Pharmaceuticals Inc., a Delaware corporation (“Guilford,” and together with GPI, “Licensor”), Symphony Neuro Development Company, a Delaware corporation (“SNDC”) (each of Licensor and SNDC being a “Party,” and collectively, the "Parties”), and SNDC Holdings LLC, a Delaware limited liability company (“Holdings”).
